Get Premium to unlock powerful stock data
NYSE:BHVN (USA)   Healthcare » Biotechnology
Biohaven Pharmaceutical Holding Co Ltd logo

Biohaven Pharmaceutical Holding Co Ltd $ 139.90 3.02 (2.21%)

Volume:
287,040
Avg Vol (1m):
368,489
Market Cap $:
9.15 Bil
Enterprise Value $:
9.06 Bil
PE Ratio:
At Loss
PB Ratio:
0.00
Warning! GuruFocus has detected 7 Severe warning signs with BHVN. Click here to check it out.
Also Trade In: Germany
EMBED
5D 3M YTD 1Y 3Y 5Y 10Y All 10Y -%
Above Low: +NaN%
Below High: NaN%

BHVN Stock Institutional Ownership and Insider Ownership - Biohaven Pharmaceutical Holding Co Ltd

65.4
(Mil)
Shares Outstanding
94.66%
61.91 (Mil)
Institutional Ownership
8.45%
5.53 (Mil)
Insider Ownership
88.74%
58.0346 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Biohaven Pharmaceutical Holding Co Ltd. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Biohaven Pharmaceutical Holding Co Ltd. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders